HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $11 Price Target

Benzinga · 03/19 11:05
HC Wainwright & Co. analyst Andres Maldonado reiterates Ikena Oncology (NASDAQ:IKNA) with a Buy and maintains $11 price target.